Alixer Nexgen Therapeutics Limited
1 clinical trials · Sponsor
◉ Watch Alixer Nexgen Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure (NCT07219849) | Alixer Nexgen Therapeutics Limited | 2025-10-17 |
Track Alixer Nexgen Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.